Certification of Human Immunoglobulin Standard Samples for Determination of Anticomplementary Activity


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

An evaluation and stability study of the original Russian human immunoglobulin standard intended for determining the anticomplementary activity and assessing the stability and acceptability of test results are reported. The certified values of the experimental anticomplementary activity of the negative control standard fell in the range 37.9 – 45.1%; of the positive control, 73.6 – 82.8% (for P = 0.95). Ashelf life of 1.5 years was justified based on the stability data of the standard sample. Introduction of the certified reference materials into the analysis of human immunoglobulin pharmaceutical preparation for intravenous administration during evaluation and quality control under government projects and confirmation of compliance with regulatory requirements will ensure that the determined anticomplementary properties are accurate.

Об авторах

M. Krivykh

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

O. Kornilova

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

N. Bunyatyan

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

E. Paramonova

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

É. Kudasheva

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

E. Novikova

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

O. Ustinnikova

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

R. Volkova

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

O. Fadeikina

Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Россия, Moscow, 127051

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media New York, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).